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Abstract In our previous studies, TPA treatment of LA-N-1
cells stimulated the production of diacylglycerol in nuclei,
probably through the activation of a phospholipase C. Stimula-
tion of the synthesis of nuclear phosphatidylcholine by the
activation of CTP:phosphocholine cytidylyltransferase was also
observed. The present data show that both effects were inhibited
by the pretreatment of the cells with D609, a selective
phosphatidylcholine-phospholipase C inhibitor, indicating that
the diacylglycerol produced through the hydrolysis of phospha-
tidylcholine in the nuclei is reutilized for the synthesis of nuclear
phosphatidylcholine and is required for the activation of
CTP:phosphocholine cytidylyltransferase. ß 2001 Published
by Elsevier Science B.V. on behalf of the Federation of Euro-
pean Biochemical Societies.
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1. Introduction
Phosphatidylcholine (PtdCho) represents the major phos-
pholipid in eukaryotic membranes where it is a fundamental
structure element as well as a reservoir for lipid mediators
generated upon appropriate cellular stimuli [1]. Its hydrolysis
by a speci¢c phospholipase C (PtdCho-PLC) [2,3] or by the
sequential activation of a phospholipase D and phosphatidate
phosphohydrolase (PLD-PPH) [4] gives rise to diacylglycerols
(DAG). DAG may stimulate the translocation and the acti-
vation of protein kinase C within the nucleus [5] leading to the
induction of long term cellular responses, such as mitosis. The
enzymic mechanisms involved in nuclear DAG production
and their possible involvement in the regulation of cellular
proliferation are the topic of only a few reports [6^8]. Our
previous data showed that the treatment of LA-N-1 cells or
nuclei with 12-O-tetradecanoylphorbol-13-acetate (TPA), a
tumor promoter, led to the production of nuclear DAG
through the activation of a PLC and/or PLD/PPH hydrolyz-
ing preferentially PtdCho. Moreover, an increase of the syn-
thesis of PtdCho was observed suggesting the presence of a
PtdCho cycle in LA-N-1 nuclei [9]. Among the three enzymes
involved in the de novo synthesis of PtdCho [10,11], only the
CTP:phosphocholine cytidylyltransferase (CCT) is activated
by TPA [12]. In order to gain insights into the mechanisms
involved in the regulation of the PtdCho cycle in the nuclei of
LA-N-1 cells when stimulated by TPA, we investigated the
e¡ect of D609 (tricyclodecan-9-yl xanthogenate), a selective
PtdCho-PLC inhibitor [13], on the production of DAG and
the synthesis of nuclear PtdCho. The pretreatment of LA-N-1
cells with D609 inhibited the production of DAG, but not
phosphatidylethanol (PtdEtOH), in the nuclei of TPA treated
LA-N-1 cells in the presence of ethanol. Moreover, D609 also
inhibited the TPA stimulation of nuclear PtdCho synthesis
and the activation of the speci¢c CCT. These observations
indicate that the DAG produced by the activation of the
speci¢c PtdCho-PLC plays a key role in the regulation of
the LA-N-1 nuclear PtdCho cycle.
2. Materials and methods
2.1. Materials
Leibovitz’s L-15 medium and fetal calf serum were supplied by Life
Technologies (Eragny, France). Streptomycin, penicillin, trypsin in-
hibitor, phenylmethylsulfonyl£uoride, TPA, phosphatidic acid and
Dowex 50U8 WH were obtained from Sigma Chemical (St. Louis,
MO, USA); PtdEtOH and D609 from Tebu S.A. (Le Parray en Yve-
lines, France); silica gel plates G 60 (Kieselgel 60, 20U20 cm; 250
WM) from Merck (Darmstadt, Germany); [14C]choline, phos-
pho[14C]choline and [3H]palmitic acid from NEN Life Science Prod-
ucts (Paris, France).
2.2. Methods: LA-N-1 cell cultures and preparation of nuclei
Human neuroblastoma LA-N-1 cells obtained from Dr. Seeger,
University of California at Los Angeles, were maintained in culture
with Leibovitz’s L-15 medium containing 15% fetal calf serum. The
medium was renewed at days 2 and 5. At day 5, the cells were prela-
beled with [3H]palmitic acid (speci¢c activity 60 Ci/mmol) for 48 h. At
day 7, the medium was removed and the cells pretreated with D609
(50 Wg/ml) or water (vehicle) for 15 min and then incubated with 160
nM TPA in DMSO (0.01%) or with DMSO (control) for 30 min in
the presence of 1% ethanol. LA-N-1 nuclei were isolated according to
the method of Antony et al. [9].
2.3. Quanti¢cation of nuclear DAG
Nuclear lipids were extracted by the method of Kiss and Crilly [14]
and lipid carrier standards were added. DAG and PtdEtOH were
separated by thin layer chromatography on silica gel G plates using
a double development system and quanti¢ed as previously reported
[9].
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2.4. Incorporation of choline into PtdCho
Incorporation of [14C]choline into PtdCho of nuclei from treated or
untreated cells was carried out according to Soto et al. [15] in a
medium containing 20 mM K2HPO4-KH2PO4 bu¡er pH 7.4, 20
mM Na pyruvate, 1.3 mM Na malate, 5.0 mM MgCl2, 1.7 mM
ATP, 0.25 mM CTP, 0.1 mM CoA, 1.7 mM CMP, 2.0 mM creatine
phosphate, 125 Wg/ml of creatine phosphokinase, 17.0 WM
[14C]choline (speci¢c activity 55 WCi/Wmol) and 0.5^1 mg protein in
a ¢nal volume of 1.0 ml. Samples were incubated at 37‡C with con-
tinuous shaking for 2 h. The reaction was stopped by the addition of
3.75 ml chloroform/methanol 1:2 (v/v) and the lipids extracted ac-
cording to the procedure of Bligh and Dyer [16]. The radioactivity
of PtdCho was determined by scintillation counting.
2.5. In vitro determination of nuclear CCT
The determination of nuclear CCT activity in LA-N-1 nuclei was
performed on vehicle and D609 treated cells as described by Tron-
che're et al. [17] in a ¢nal volume of 100 Wl. The incubation mixture
contained 20 mM Tris^succinate pH 7.8, 6 mM MgCl2, 8 mM CTP,
4 mM phospho[14C]choline (speci¢c activity 0.5 WCi/Wmol) and up to
0.3 mg of nuclear protein. The reaction was stopped by addition of 50
Wl perchloric acid 1.5 M. After centrifugation at 3000Ug, the super-
natant was neutralized with 150 Wl NaOH 1 M and the CDP-
[14C]choline separated by column chromatography on Dowex-50-
WH and the radioactivity measured by scintillation counting.
2.6. Protein determination
The protein content was determined by the method of Lowry et al.
[18] using bovine serum albumin as the standard.
2.7. Statistics
The data represent the mean of three experiments performed in
triplicate and analyzed utilizing Student’s t-test.
3. Results
3.1. Production of DAG in nuclei
The treatment of the cells with TPA in the presence of
ethanol led to a strong enhancement of DAG in nuclei after
5 min. The level of DAG remained constant between 5 and 15
min and increased thereafter up to 30 min (Fig. 1). As ex-
pected, the production of nuclear PtdEtOH was higher in
TPA treated cells as compared to control, but did not change
whatever the time of incubation (not shown).
3.2. E¡ect of D609 on the production of DAG in nuclei
The signaling pathway involved in the production of nu-
clear DAG was investigated with D609. Preincubation of the
cells with D609 had no e¡ect on the basal level of nuclear
DAG of control cells. Nevertheless, this pretreatment led to
inhibition by about 75% of the DAG production in nuclei of
TPA stimulated cells in the presence of ethanol (Fig. 2).
3.3. E¡ect of D609 on the PtdCho synthesis in nuclei
Treatment of the cells with TPA stimulated the incorpora-
tion of choline into nuclear PtdCho (Fig. 3A), suggesting that
the DAG produced may be reutilized as substrate. Preincuba-
tion of the cells with D609 switched o¡ the stimulation of the
incorporation of choline into the nuclear PtdCho.
Since the de novo synthesis of nuclear PtdCho seems to be
regulated by the activation of the CCT and not that of choline
kinase and CDP-choline DAG phosphocholine transferase [9],
it was important to determine if the nuclear DAG produced in
TPA stimulated cells were necessary for the activation of CCT
in nuclei. Pretreatment of the cells with D609 completely abol-
ished the activation of nuclear CCT induced by the treatment
of cells with TPA (Fig. 3B).
Fig. 1. E¡ect of TPA stimulation of LA-N-1 cells on the production
of DAG in nuclei. The experimental details are described in Section
2. Dashed lines represent the control cells and the solid lines the
TPA treated cells. **P6 0.01.
Fig. 2. E¡ect of D609 on the production of DAG in nuclei of TPA
stimulated LA-N-1 cells. The experimental details are described in
Section 2. The open bars represent the control incubations and the
¢lled bars the TPA treated cells. ***P6 0.001 against vehicle.
Fig. 3. E¡ect of D609 on the synthesis of PtdCho in nuclei of TPA
treated LA-N-1 cells. A represents the incorporation of choline into
PtdCho and B the speci¢c activity of nuclear CCT. The experimen-
tal details are described in Section 2. The open bars represent the
control incubations and the ¢lled bars the TPA incubations.
***P6 0.001 against vehicle.
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4. Discussion
This study was focussed on the production of nuclear DAG
in order to determine which phospholipases and substrates are
involved in long term cellular responses such as proliferation.
Classically, the hydrolysis of phosphoinositides by a phospha-
tidylinositol (PtdIns)-PLC is considered to be the major mech-
anism for rapid DAG generation, whereas PtdCho breakdown
contributes mainly to DAG production during a longer time
after stimulation [19,20]. Thus, PtdCho may be the main sub-
strate utilized for the production of DAG in the nuclei of LA-
N-1 cells stimulated with TPA for 5 and 30 min. Previous
results have shown that TPA treated LA-N-1 nuclei led to
the increase of water soluble choline compounds, especially
phosphocholine. Moreover the same stimulation of nuclei
prelabeled with palmitate also induced the production of la-
beled DAG, suggesting the activation of a PLC catalyzing the
hydrolysis of PtdCho [9]. Although the same stimulation pro-
duced an activation of a nuclear PLD, its involvement in the
production of DAG has been excluded because the experi-
ments were conducted in the presence of ethanol; PLD cata-
lyzes the formation of [3H]PtdEtOH, which is not dephos-
phorylated into DAG [21]. To con¢rm this hypothesis, the
e¡ect of D609, a selective PtdCho-PLC inhibitor, on the pro-
duction of DAG in nuclei of TPA treated cells has been in-
vestigated. The dramatic decrease in the DAG generation in
the nuclei of D609 pretreated cells stimulated by TPA indi-
cates the activation of a PtdCho-PLC by TPA [22]. The ob-
servation that D609 treatment of the cells did not inhibit
completely the nuclear DAG production suggests that the hy-
drolysis of phospholipids like PtdEtn may contribute a small
amount of DAG [23].
Earlier experiments also have shown that TPA induced a
stimulation of the PtdCho synthesis in LA-N-1 nuclei as has
been reported in SK-N-SH human neuroblastoma cells [24]
and that DAG produced by the treatment of LA-N-2 cells
by exogenous PLC activated the CCT [25]. The observation
suggests that the nuclear DAG generated upon the degrada-
tion of PtdCho may be of prime importance in the activation
of PtdCho synthesis.
The data showing that the pretreatment of LA-N-1 cells by
D609 completely inhibited the TPA stimulation of the choline
incorporation into nuclear PtdCho con¢rm this hypothesis
and indicate the existence of a correlation between the pro-
duction of DAG through the activation of PtdCho-PLC and
the stimulation of PtdCho synthesis. The DAG produced
upon PtdCho-PLC activation may be utilized as substrate
by the CDP:choline DAG phosphocholine transferase cata-
lyzing the last step of PtdCho de novo synthesis and/or as
activator of the CCT induced by cellular TPA. The fact that
the D609 pretreatment of LA-N-1 cells completely inhibited
the activation of CCT induced by the DAG generated by
cellular TPA stimulation indicates that the newly produced
DAG molecules are required for the activation of this enzyme.
Three isoforms of CCT have been described. CCTK is an
ubiquitous enzyme that contains at its N-terminal region a
signal peptide of 21 amino acids su⁄cient for nuclear local-
ization [26], whereas CCTL1 and CCTL2 lack this signal [27].
The nuclear localization of CCTK and its close relationship
with the activation of synthesis of PtdCho in mammalian cells
is widely debated [28,29]. Our results suggest that a nuclear
CCTK is activated by the DAG generated upon TPA treat-
ment of LA-N-1 cells, which enhances in turn the de novo
synthesis of PtdCho in nuclei. Chromatin from human IRM-
32 neuroblastoma cells possesses the three enzymes of the
Kennedy pathway necessary for endonuclear synthesis of
PtdCho, which may then be involved in cell proliferation [30].
Whereas several studies have elicited the enzymic mecha-
nisms of a nuclear PtdIns cycle [31,32], the existence and the
regulation of nuclear PtdCho cycle have not been well de¢ned.
Our results show for the ¢rst time that TPA treatment of LA-
N-1 cells activates in the nuclei a PtdCho-PLC, leading to the
production of DAG, which in turn induces the stimulation of
PtdCho synthesis by the speci¢c activation of CCT. Such a
mechanism may equilibrate the nuclear pool of PtdCho for
cellular homeostasis. Altogether these results indicate the ex-
istence of a nuclear PtdCho cycle in LA-N-1 neuroblastoma
cells that may be involved in nuclear functions such as DNA
synthesis and cell proliferation.
Acknowledgements: Supported by Ligue Nationale contre le Cancer
and by research grants NS-10165 and NS-29441 from the National
Institutes of Health, US Public Health Service. P.A. acknowledges
¢nancial assistance of the Fondation pour la Recherche Me¤dicale
(FRM).
References
[1] Exton, J.H. (1994) Biochim. Biophys. Acta 1212, 26^42.
[2] Zhang, F., Zhao, G. and Dong, Z. (2001) J. Leukoc. Biol. 69,
1060^1066.
[3] Van Dijk, M.C.M., Muriana, F.J.G., De Widt, J., Hilkmann, H.
and Van Blitterswijk, W.J. (1997) J. Biol. Chem. 272, 11011^
11016.
[4] Sciorra, V.A. and Morris, A.J. (1999) Mol. Biol. Cell 10, 3863^
3876.
[5] Neri, L.M., Borgatti, P., Capitani, S. and Martelli, A.M. (1998)
J. Biol. Chem. 273, 29738^29744.
[6] Ban¢c, H., Zizak, M., Divecha, N. and Irvine, R.F. (1993) Bio-
chem. J. 290, 633^636.
[7] Divecha, N., Treagus, J., Vann, L. and D’Santos, C. (1997)
Semin. Cell Dev. Biol. 8, 323^331.
[8] Raben, D.M. and Baldassare, J.J. (2000) Adv. Enzyme Regul. 40,
97^123.
[9] Antony, P., Kanfer, J.N. and Freysz, L. (2000) Neurochem. Res.
25, 1073^1082.
[10] Kennedy, E.P. and Weiss, S.B. (1956) J. Biol. Chem. 222, 193^
214.
[11] Clement, J.M. and Kent, C. (1999) Biochem. Biophys. Res. Com-
mun. 257, 643^650.
[12] Utal, A.K., Jamil, H. and Vance, D.E. (1991) J. Biol. Chem. 266,
24084^24091.
[13] Kiss, Z. and Tomono, M. (1995) Biochim. Biophys. Acta 1259,
105^108.
[14] Kiss, Z. and Crilly, K.S. (1991) Lipids 26, 777^780.
[15] Soto, E.F., Pasquini, J.M. and Krawiec, L. (1972) Arch. Bio-
chem. Biophys. 150, 362^370.
[16] Bligh, E.G. and Dyer, W.J. (1959) Can. J. Biochem. Physiol. 37,
911^917.
[17] Tronche're, H., Planat, V., Record, M., Terce¤, F., Ribbes, G. and
Chap, H. (1995) J. Biol. Chem. 270, 13138^13146.
[18] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J.
(1951) J. Biol. Chem. 193, 265^275.
[19] Pessin, M.S. and Raben, D.M. (1989) J. Biol. Chem. 264, 8729^
8738.
[20] Leach, K.L., Ru¡, V.A., Jarpe, M.B., Adams, L.D., Fabbro, D.
and Raben, D.M. (1992) J. Biol. Chem. 267, 21816^21822.
[21] Kanfer, J.N., McCartney, D., Singh, I.N. and Freysz, L. (1996)
J. Neurochem. 67, 760^766.
[22] Schutze, S., Pottho¡, K., Machleidt, T., Berkovic, D., Wieg-
mann, K. and Kronke, M. (1992) Cell 71, 765^776.
[23] Jarpe, M.B., Leach, K.L. and Raben, D.M. (1994) Biochemistry
33, 526^534.
FEBS 25537 26-11-01
P. Antony et al./FEBS Letters 509 (2001) 115^118 117
[24] Sproull, S.A., Morash, S.C., Byers, D.M., Palmer, F.B.S. and
Cook, H.W. (1995) Neurochem. Res. 20, 1397^1407.
[25] Slack, B.E., Breu, J. and Wurtman, R.J. (1991) J. Biol. Chem.
266, 24503^24508.
[26] Wang, Y., MacDonald, J.I.S. and Kent, C. (1995) J. Biol. Chem.
270, 354^360.
[27] Lykidis, A., Baburina, I. and Jackowski, S. (1999) J. Biol. Chem.
274, 26992^27001.
[28] DeLong, C.J., Qin, L. and Cui, Z. (2000) J. Biol. Chem. 275,
32325^32330.
[29] Northwood, I.C., Tong, A.H., Crawford, B., Drobnies, A.E. and
Cornell, R.B. (1999) J. Biol. Chem. 274, 26240^26248.
[30] Hunt, A.N., Clark, G.T., Attard, G.S. and Postle, A.D. (2001)
J. Biol. Chem. 276, 8492^8499.
[31] Clarke, J.H., Letcher, A.J., D’Santos, C.S., Halstead, J.R.,
Irvine, R.F. and Divecha, N. (2001) Biochem. J. 357, 905^
910.
[32] Maraldi, N.M., Zini, N., Santi, S. and Manzoli, F.A. (1999)
J. Cell Physiol. 181, 203^217.
FEBS 25537 26-11-01
P. Antony et al./FEBS Letters 509 (2001) 115^118118
